Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AXADIA: Apixaban vs Phenprocoumon in AF Patients on Hemodialysis
NCT02933697Phase 3Completed
- Sponsor
- Kompetenznetz Vorhofflimmern
- Start
- Jun 2017
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apixaban in Atrial fibrillation (AFib), sponsored by Kompetenznetz Vorhofflimmern. Started Jun 2017; status: completed.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02933697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02933697.